Suppression of p300 acetyltransferase activity by natural molecules (curcumin) or synthetic small molecule inhibitors of p300 (L002 or C646) leads to slowdown or reversal of cardiac aging pathologies induced by hypertension, diabetes, and other stress (Rai et al., 2017, 2019). Here, EP300 is linked to hypertensive disorder.